Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
T

CAR-T Cell Therapy in Chronic Lymphocytic Leukemia (CLL): Manageable Toxicity and Promising Clinical Activity of Liso-Cel

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Tanya Siddiqi
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Tanya Siddiqi
0 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
Chronic Lymphocytic Leukemia
13:15
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Shifting Standard of Care for Frontline Therapy of CLL: Which Patien…

Feat. N. Jain
11:37
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CLL State of the Art Update: Ibrutinib Prolongs PFS Compared to CIT,…

Feat. J. Brown
15:20
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Discussion on the Next Generation Small Molecules in CLL: 2nd Genera…

Feat. J. Woyach
05:46
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

62 y/o Male Diagnosed With CLL, Treated w/Mono Retuximab, Differenti…

Feat. A. Ferrajoli
04:13
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

72 y/o Female w/Relapsed Rai Stage IV CLL Treated w/Ibrutinib and Ri…

Feat. A. Ferrajoli
06:07
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

63 y/o Male w/Untreated CLL Rai I, Acute Hepatitis and Fever Work-Up…

Feat. A. Ferrajoli
13:11
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CAR-T Cell Therapy in Chronic Lymphocytic Leukemia (CLL): Manageable…

Feat. T. Siddiqi
16:05
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Reassessing Prognostic Markers (IGHV, TP53, CD49d, and B2M) in the E…

Feat. A. Wiestner
06:23
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

BTKi Acalabrutinib with anti-CD20 Obinutuzumab in Treatment-Naive an…

Feat. J. Woyach
07:41
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CLL and Therapy Related Myeloid Neoplasia in Chemoimmunotherapy Era:…

Feat. A. Lenartova